益气活血汤治疗气虚血瘀型冠心病慢性心衰临床观察

目的观察自拟益气活血汤治疗气虚血瘀型冠心病慢性心衰的疗效。方法将97例冠心病慢性心衰且中医辨证属气虚血瘀型患者随机分为两组,治疗组51例在常规西药抗心衰治疗的基础上加服中药益气活血汤治疗;对照组46例仅采用常规抗心衰西药治疗。结果治疗组临床疗效总有效率为86.3%,对照组为76.1%;且治疗组在体表心电图疗效、心脏指数、每搏指数、射血分数改善方面均优于对照组(P0.05或P0.01)。结论益气活血汤治疗气虚血瘀型冠心病慢性心衰疗效显著。     

自拟益气活血汤治疗冠心病气虚血瘀型30例疗效观察

目的:观察自拟益气活血汤治疗冠心病气虚血瘀型的临床疗效.方法:将60例患者随机分为两组各30例,治疗组用自拟益气活血汤,对照组应用消心痛片治疗,疗程均为4周,观察两组治疗疗效.结果:总有效率治疗组为93.3%,对照组为73.3%,两组比较,差异有非常显著性意义(P＜0.01).结论:自拟益气活血汤治疗冠心病气虚血瘀型疗效好.     

中西医结合治疗气虚血瘀型稳定型心绞痛疗效观察

目的:观察自拟益气活血汤配合西药治疗气虚血虚型稳定型心绞痛的临床疗效。方法:患者随机分为两组,对照组口服消心痛,治疗组在对照组基础上加服自拟益气活血汤。结果:治疗组有效率91.6%,对照组82.5%。两组比较,差异有显著性意义(P<0.05),且治疗组心电图改善率高于对照组。结论:中西医结合治疗气虚血瘀型稳定型心绞痛疗效好。     

益气活血法治疗气虚血瘀型冠心病心绞痛30例临床观察

目的:观察益气活血法治疗气虚血瘀型冠心病心绞痛的疗效.方法:将60例符合诊断标准的患者随机分为治疗组和对照组,每组30例.2组基础治疗相同,治疗组再给予益气活血汤加减.结果:治疗组症状总有效率90.00%,心电图总有效率86.67%,心绞痛发作次数、程度、持续时间总有效率为93.33%;对照组症状总有效率为76.67%,心电图总有效率为66.67%,心绞痛发作次数、程度、持续时间总有效率为80%.治疗组与对照组比较有显著差异(P＜0.05).结论:益气活血法是治疗气虚血瘀型冠心病心绞痛的有效方法.     

益气活血通脉汤联合电针治疗脑梗死恢复期30例总结

目的:观察益气活血通脉汤联合电针治疗脑梗死恢复期(气虚血瘀型)的临床疗效。方法:治疗组30例在西医常规治疗的基础上加用益气活血通脉汤联合电针治疗,对照组30例采用西医常规治疗。结果:治疗组总有效率为90.00%,对照组为76.67%,两组比较差异有统计学意义(P0.05);治疗组在神经功能缺损评分差值、血液流变学改善等方面均优于对照组(P0.01)。结论:益气活血通脉汤联合电针治疗脑梗死恢复期(气虚血瘀型)有良好的疗效。     

益气活血汤联合西药治疗气虚血瘀型冠心病心绞痛的临床观察

目的观察益气活血汤联合西药治疗气虚血瘀型冠心病心绞痛的临床疗效。方法随机将2014年3月—2017年12月收治的84例气虚血瘀型冠心病心绞痛患者分为对照组和实验组2组,对照组44例应用常规西药治疗、实验组40例在对照组的基础上联合益气活血汤治疗。对2组患者治疗前后的临床疗效、炎症因子水平、中医主要症状积分进行观察和对比。结果实验组患者总有效率相比对照组明显更高,P 0. 05;实验组患者治疗后TNF-α、IL-6、CRP相比对照组明显更低,P 0. 05;实验组患者治疗后胸痛、胸闷及心悸评分相比对照组明显更低,P 0. 05。结论对气虚血瘀型冠心病心绞痛患者实施益气活血汤联合西药治疗具有较佳的效果。     

补阳还五汤化裁治疗气虚血瘀型老年冠心病疗效观察

目的：观察补阳还五汤化裁治疗气虚血瘀型老年冠心病的临床疗效。方法：将76例老年冠心病（气虚血瘀型）患者随机分为两组,治疗组40例,用补阳还五汤化裁治疗;对照组36例用鲁南欣康治疗,两组病例有合并症者均给予常规对症治疗,28d为1个疗程,观察两组疗效。结果：1个疗程后有效率,治疗组显著高于对照组（P〈0.05）。结论：补阳还五汤化裁治疗气虚血瘀型老年冠心病疗效好。     

益气活血化瘀汤对冠心病气虚血瘀证患者冠脉血流储备分数的影响

目的:探讨益气活血化瘀汤对冠心病气虚血瘀证患者冠脉血流储备分数(fractional flow reserve,FFR)的影响。方法:将108例冠心病气虚血瘀证患者随机分为对照组和治疗组各54例。治疗组采用益气活血化瘀汤治疗,对照组采用常规西药治疗。比较两组患者治疗前后中医证候积分、FFR的变化情况及不良反应发生情况,并对两组临床疗效进行评价。结果:与治疗前比较,两组患者FFR在治疗后均明显上升,中医证候积分均下降,差异均有统计学意义(P0.05);治疗组治疗后FFR高于对照组,中医证候积分低于对照组,差异均有统计学意义(P0.05);治疗组总有效率为92.59%,对照组总有效率为74.07%,治疗组优于对照组,差异有统计学意义(P0.05);不良反应发生率治疗组为1.85%,对照组为18.52%,治疗组低于对照组,差异有统计学意义(P0.05)。结论:益气活血化瘀汤治疗冠心病气虚血瘀证有较好临床疗效,可缓解患者临床症状,提高FFR。     

三七补阳还五汤治疗中风后遗症35例

目的：观察三七补阳还五汤治疗气虚血瘀型中风后遗症的临床疗效。方法：将70例气虚血瘀型中风后遗症患者随机分为两组。治疗组35例,给予三七补阳还五汤,每日1剂,水煎服。对照组35例,以银杏叶胶囊、阿斯匹林治疗。两组均连续治疗2月并随访1月后对比观察临床疗效。结果：治疗组和对照组总有效率分别为94.29%和71.43%,两组总有效率比较差异有统计学意义（P〈0.05）,治疗组无不良反应发生。结论：三七补阳还五汤治疗气虚血瘀型中风后遗症的临床疗效可靠。     

益气活血汤治疗气虚血瘀型冠心病慢性心衰临床观察

目的:探究在气虚血瘀型冠心病慢性心衰的临床治疗中,采用中医益气活血汤,观察其临床应用效果。方法:选取2014年8月-2016年1月来本院接受诊治的84例气虚血瘀型冠心病慢性心衰病人作为研究的案例,根据随机数字表法,将其分为探究组和比较组,每组42例,比较组病人给予常规西药诊治,探究组病人在给予常规西药治疗的同时,采用中医益气活血汤治疗,对比两组疗效。结果:探究组有效率高达92.86%;比较组有效率达到76.19%,存在显著差异,具有统计学意义(P0.05)。结论:在气虚血瘀型冠心病慢性心衰的临床治疗中采用中医益气活血汤具有良好的治疗效果,可有效改善病人心功能状况。     

阳微阴弦-气虚血瘀-益气活血与冠状动脉粥样硬化性心脏病

冠状动脉粥样硬化性心脏病属"胸痹""心痛"范畴,"阳微阴弦"是对胸痹病因病机的高度概括,"阳微,寸口脉微也,(关前为阳)阳得阴脉,为阳不及,上焦阳虚也;阴弦,尺中脉弦也,(关后为阴)阴得阴脉,为阴太过,下焦阴实也。凡阴实之邪,皆得以上乘阳虚之胸,所以病胸痹心痛"。气虚是发生发展基础,气虚血瘀是病机关键。宜辨证与辨病结合,灵活运用益气活血法,临床疗效显著。未来应开展大样本多中心随机实验,运用循证医学手段,系统深入研究,为中医药治疗冠状动脉粥样硬化性心脏病提供理论依据。     

试论肝生血气与肝藏血

结合传统中医理论和现代医学理论,进一步阐明肝为血气化生之所的实质及其与肝藏血的关系,为正确认识诸多肝病的病理特点和进行临床治疗提供理论依据,     

高血压急症从气血论治

探讨高血压急症病因病机与证候的关系，为中医药救治高血压急症提供新的思路与方法。肝之疏泄失常，肝不藏血，内生风火热毒，气血逆乱乃高血压急症的主要病机。清除“内毒”，调和气血是救治高血压急症的关键。     

胃癌从气血论治

从胃癌的病因病机与气血的关系及胃癌的治疗方法方面阐述了胃癌应以气血理论为纲,以气血同治为大法,立疏肝调气,理气化痰,活血化瘀,健脾益气四项主要治则进行辨治。     

益气活血法治疗气虚血瘀型糖尿病肾病35例

目的:观察益气活血法治疗气虚血瘀型糖尿病肾病的临床疗效及对血脂水平的影响.方法:选取气虚血瘀型糖尿病肾病患者70例,按照随机数字表法分为观察组和对照组,每组35例.两组患者均给予低盐、低脂饮食,控制血压、血糖等对症支持治疗,观察组另加用当归补血汤治疗.结果:观察组有效率为85.7％,对照组有效率为74.3％,观察组优于对照组(P＜0.05);观察组在降低血脂、24 h尿蛋白、改善肾功能和血脂水平等方面明显优于对照组(P均＜0.05).结论:益气活血法可有效改善糖尿病肾病患者蛋白尿及临床症状,改善患者血脂水平,发挥肾功能保护作用.     

浅谈从气血论治缺血性脑卒中

气血失调是疾病产生的根本原因,也是中风病的基本病机,祖国医学在诊治中风病上积累了丰富的经验,尤其是从气血论治方面,文章将从气血辨证关系、理论基础和方药研究三个方面进行论述。     

Special Issue on Qi Deficiency and Blood Stasis

正Qi deficiency and blood stasis is a common feature in coronary heart disease,cardiac hypertrophy,myocardial ischemia-reperfusion injury and heart failure,for which there is a lack of effective prevention and treatment methods in modern medicine.Some traditional Chinese medicine (TCM) has shown beneficial effect on heart diseases in clinic,and increasing clinical and basic studies have been carried out devoting to the mechanism behand these medicines,particularly focusing on their potential of tonifying Qi and promoting blood circulation,as well as the scientific essence of the Qi deficiency and Blood Stasis.In order to exchange the latest research results in this field,we have organized special issues of Qi deficiency and blood stasis,tonifying Qi and promoting blood circulation.Experts from this field are welcome to contribute original research articles or reviews.     

从气血辨治子宫肌瘤

目的:探讨从气血辨治子宫肌瘤。方法:通过对子宫肌瘤的诊治,结合相关文献资料以气血相关立论辨治子宫肌瘤。结论:子宫肌瘤的辨证,重在辨气血,辨虚实,在后期往往虚实夹杂,易成痼疾,所以审证求因,治法也应随气血而"变",调气行血为其根本,以衡为期。     

Study on the Biological Basis of Qi,Blood, and Vessel in Immune Thrombocytopenia Patients With Syndrome of Qi Failing to Govern Blood Based on the Theory of Qi and Blood

Objective: To investigate the biological basis of qi, blood and vessel in immune thrombocytopenia(ITP) patients with syndrome of qi failing to govern blood(SQFGB) based on traditional Chinese medicine.Methods: A total of 52 ITP patients with SQFCB were enrolled and divided into bleeding group(38 cases) and non-bleeding group(14 cases).Bleeding group was further divided into mild qi deficiency group(25 cases) and moderate/severe qi deficiency group(13 cases) based on Chinese Medicine syndrome score.20 healthy volunteer were recruited as control group.The count of platelet(PLT) was taken as the blood related indicator.The expressions of cytokines including IL-1β, IL-17 A, TNF-α, CD40 L, and TGF-β, detected by Aim Plex Multiple Immunoassays for Flow, were taken as the qi related indicators.The expressions of VEGF-A, detected by Aim Plex Multiple Immunoassays for Flow and NO, NOS, and ET-1 detected by ELISA, were taken as the vessel related indicators.Results: As compared to the control group, the count of PLT, taken as the blood related indicator, was significantly lower in ITP group patients with SQFCB(P<0.05).The expression levels of IL-17 A and TNF-α, taken as the qi related indicators, were significantly higher, while those of CD40 L, IL-1β, and TGF-β, also taken as the qi related indicators, were significantly lower in ITP patients with SQFCB, respectively(P<0.05).The expression levels of NO and ET-1, taken as the vessel related indicators, were significantly higher, while the expression levels of NOS and VEGF-A also taken as the vessel related indicators, were significantly lower in ITP patients with SQFCB, respectively(P<0.05).The count of PLT, taken as the blood related indicator, was significantly lower in moderate/severe group than those in mild group(P<0.05).The expression levels of CD40 L and TGF-β, taken as the qi related indicators, were also significantly lower in moderate/severe group than those in mild group, respectively(P<0.05).Conclusion: The count of PLT might be the biological basis of blood.The expressions of NO, NOS, ET-1 and VEGF-A might be the biological basis of vessel.The expressions of IL-1β, IL-17 A, TNF-α, TGF-β, and CD40 L may be the biological basis of qi.The expressions of CD40 L and TGF-β could reflect the degree of qi deficiency in ITP patients based on the theory of qi and blood.